Niki BioSolutions, Inc. Net Income (Loss) Attributable to Noncontrolling Interest
Niki BioSolutions, Inc. (NIKI) reported Net Income (Loss) Attributable to Noncontrolling Interest of -$13.16 thousand for the 12-month period ending 2025-12-31, per its S-4/A filed 2026-05-11.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2026-05-11
- Niki BioSolutions, Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-12-31 was -$3.04K, a 102.04% decline year-over-year.
- Niki BioSolutions, Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-09-30 was -$2.60K.
- Niki BioSolutions, Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2024-12-31 was $149.55K.
- Niki BioSolutions, Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2024-09-30 was -$24.39K.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Noncontrolling Interest 10 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-12-31 | -$3.04K derived: S-4/A 12 month − 6-K 9 month · filed 2026-05-11 | -$5.64K derived: sum of 2 quarters · filed 2026-05-11 | -$13.16K S-4/A · filed 2026-05-11 | |||
| 2025-09-30 | -$2.60K derived: 6-K 9 month − 6-K 6 month · filed 2026-01-22 | -$10.12K 6-K · filed 2026-01-22 | ||||
| 2025-06-30 | -$7.51K 6-K · filed 2025-10-08 | |||||
| 2024-12-31 | $149.55K derived: S-4/A 12 month − 6-K 9 month · filed 2026-05-11 | $125.16K derived: sum of 2 quarters · filed 2026-05-11 | $110.07K S-4/A · filed 2026-05-11 | |||
| 2024-09-30 | -$24.39K derived: 6-K 9 month − 6-K 6 month · filed 2026-01-22 | -$39.48K 6-K · filed 2026-01-22 | ||||
| 2024-06-30 | -$15.09K 6-K · filed 2025-10-08 | |||||
| 2023-12-31 | -$1.52M S-4/A · filed 2026-05-11 | |||||
| 2023-06-30 | -$1.12M 6-K · filed 2024-12-20 | |||||
| 2022-12-31 | -$1.73M 6-K · filed 2025-10-08 | |||||
| 2022-06-30 | -$844.54K 6-K · filed 2023-12-22 | |||||
| 2021-12-31 | -$2.07M 20-F · filed 2024-04-30 | |||||
| 2021-06-30 | -$1.02M 6-K · filed 2022-09-30 | |||||
| 2020-12-31 | $2.15M 20-F · filed 2021-04-19 | |||||
| 2020-06-30 | -$783.75K 6-K · filed 2021-09-15 | |||||
| 2019-12-31 | $1.43M 20-F · filed 2021-04-19 | -$1.43M 20-F · filed 2020-04-29 | ||||
| 2019-06-30 | -$551.88K 6-K · filed 2020-09-02 | |||||
| 2018-12-31 | $302.76K 20-F · filed 2021-04-19 | -$302.76K 20-F · filed 2019-04-15 | ||||
| 2017-12-31 | -$14.04K 20-F · filed 2020-04-29 |